In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vistakon

Division of Johnson & Johnson
www.jnjvision.com

Latest From Vistakon

Together Rx Patient Assistance Program Will Close When ACA Coverage Expansion Begins

The move to shutter the program is noteworthy because it suggests the beginning of a trend among patient assistance programs for drugs as the uninsured gain coverage through state marketplaces or Medicaid.

BioPharmaceutical United States

Bausch & Lomb Sold To Valeant Pharmaceuticals For $8.7 Billion

In the latest of more than a dozen acquisitions Valeant has made since it was created by a merger with Biovail SA in 2011, Valeant’s purchase of Bausch & Lomb will increase its eye care portfolio substantially.

Medical Device

Eye On The Prize: For $8.7 Billion, Valeant Will Acquire Bausch & Lomb

As with its Medicis buyout in 2012, Valeant is acquiring another company to serve essentially as a therapeutic division within the specialty pharma the Canadian firm is cobbling together from relentless M&A activity. Buying B&L will increase Valeant’s eye care holdings substantially.

BioPharmaceutical Consumer

Eye On The Prize: For $8.7 Billion, Valeant Will Acquire Bausch & Lomb

As with its Medicis buyout in 2012, Valeant is acquiring another company to serve essentially as a therapeutic division within the specialty pharma the Canadian firm is cobbling together from relentless M&A activity. Buying B&L will increase Valeant’s eye care holdings substantially.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Johnson & Johnson
  • Senior Management
  • Contact Info
  • Vistakon
    Phone: (904) 443-1000
    4500 Salisbury Rd.
    Jacksonville, FL 32216
    USA
UsernamePublicRestriction

Register